Bespoke Extracts (BSPK) Cash from Operations Growth (5y) (2016 - 2021)
Bespoke Extracts (BSPK) Cash from Operations Growth (5y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | 15.76% |
| Aug 31, 2021 | -94.29% |
| May 31, 2021 | -58.21% |
| Feb 28, 2021 | -31.31% |
| Nov 30, 2020 | -26.30% |
| May 31, 2020 | -3.75% |
| Feb 29, 2020 | -17.79% |
| Nov 30, 2019 | -19.47% |
| Aug 31, 2019 | -9.93% |
| May 31, 2019 | -6.22% |
| Feb 28, 2019 | -1.70% |
| Nov 30, 2018 | 0.62% |
| Aug 31, 2018 | -45.82% |
| May 31, 2018 | -23.21% |
| Feb 28, 2018 | -3.96% |
| Nov 30, 2017 | -6.03% |
| May 31, 2017 | 3.62% |
| Feb 28, 2017 | 38.33% |
| Nov 30, 2016 | 23.80% |